Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.22M Sell
11,650
-30
-0.3% -$10.3K 0.84% 38
2026
Q1
$4.11M Sell
11,680
-254
-2% -$90.5K 0.92% 35
2025
Q4
$3.91M Buy
11,934
+244
+2% +$77.4K 0.87% 38
2025
Q3
$3.3M Buy
11,690
+290
+3% +$84.1K 0.75% 46
2025
Q2
$3.18M Buy
11,400
+624
+6% +$177K 0.76% 46
2025
Q1
$3.36M Sell
10,776
-331
-3% -$97.7K 0.87% 37
2024
Q4
$2.89M Buy
11,107
+371
+3% +$110K 0.74% 45
2024
Q3
$3.46M Buy
10,736
+3,131
+41% +$1.02M 0.87% 41
2024
Q2
$2.38M Buy
7,605
+2,727
+56% +$801K 0.63% 49
2024
Q1
$1.39M Buy
4,878
+919
+23% +$269K 0.37% 76
2023
Q4
$1.14M Buy
3,959
+8
+0.2% +$2.18K 0.33% 77
2023
Q3
$1.06M Sell
3,951
-20
-0.5% -$4.99K 0.33% 79
2023
Q2
$882K Sell
3,971
-50
-1% -$11.6K 0.26% 89
2023
Q1
$972K Sell
4,021
-230
-5% -$56.5K 0.3% 86
2022
Q4
$1.12M Sell
4,251
-165
-4% -$44.2K 0.36% 80
2022
Q3
$996K Sell
4,416
-30
-0.7% -$7.27K 0.34% 83
2022
Q2
$1.08M Sell
4,446
-562
-11% -$138K 0.34% 86
2022
Q1
$1.21M Sell
5,008
-1,365
-21% -$314K 0.32% 89
2021
Q4
$1.43M Buy
6,373
+275
+5% +$58K 0.36% 81
2021
Q3
$1.3M Buy
6,098
+190
+3% +$43.7K 0.37% 78
2021
Q2
$1.44M Sell
5,908
-674
-10% -$166K 0.4% 77
2021
Q1
$1.64M Sell
6,582
-508
-7% -$121K 0.48% 67
2020
Q4
$1.63M Buy
7,090
+200
+3% +$46.1K 0.51% 61
2020
Q3
$1.75M Buy
6,890
+255
+4% +$63.2K 0.59% 55
2020
Q2
$1.56M Sell
6,635
-1,836
-22% -$419K 0.56% 57
2020
Q1
$1.72M Sell
8,471
-145
-2% -$31.7K 0.72% 42
2019
Q4
$2.08M Sell
8,616
-487
-5% -$107K 0.67% 46
2019
Q3
$1.76M Sell
9,103
-1,160
-11% -$223K 0.58% 57
2019
Q2
$1.89M Sell
10,263
-287
-3% -$51.4K 0.62% 53
2019
Q1
$2M Buy
10,550
+215
+2% +$41.1K 0.67% 48
2018
Q4
$2.01M Sell
10,335
-190
-2% -$37.1K 0.74% 44
2018
Q3
$2.18M Sell
10,525
-97
-0.9% -$19.1K 0.71% 46
2018
Q2
$1.96M Buy
10,622
+300
+3% +$53.1K 0.67% 51
2018
Q1
$1.76M Buy
10,322
+1,117
+12% +$205K 0.61% 55
2017
Q4
$1.6M Buy
+9,205
New +$1.63M 0.57% 58

Other funds holding AMGN

Plimoth Trust's AMGN Position: Q2 2026 in Review

Plimoth Trust reduced its Amgen (AMGN) stake by 0.26% in Q2 2026, selling an estimated $10.3K and leaving 11,650 shares worth $4.22M. The position accounts for 0.84% of the portfolio, ranked #38.

Plimoth Trust first reported a position in AMGN in Q4 2017 and has held it in 35 quarters since. 1,282 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Plimoth Trust held 11,650 shares of Amgen worth $4.22M as of Q2 2026.
  • Plimoth Trust sold 30 Amgen shares in Q2 2026, an estimated $10.3K.
  • Amgen made up 0.84% of Plimoth Trust's portfolio in Q2 2026, its #38 holding.
  • Plimoth Trust first reported a position in Amgen in Q4 2017 and has held it in 35 quarters since.
  • 1,282 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Plimoth Trust's 13F filing for Q2 2026, filed 28 Jul 2026.